NSPR
InspireMD, Inc.
NasdaqCMUSDEQUITY
Healthcare
DELAYED
Sell
-49/100
Last price
0.53
▼ 0.07 (11.04%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
0.59
Day high
0.62
Day low
0.50
Volume
230.02K
Market cap
$24.42M
P/E (TTM)
—
52W range
0.50 – 2.54
Trailing performance
Returnvs SPY
1W
-23.19%
-25.1%
1M
-37.65%
-38.8%
3M
-23.19%
-27.7%
6M
-61.87%
-80.1%
YTD
-70.22%
-84.5%
1Y
-77.82%
-94.2%
3Y
-83.79%
-166.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on NSPR open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+309.10K
Net buying
Buy transactions
8
394.40K shares
Sell transactions
1
85.30K shares
Net transactions
+9
Buys less sells
Sell : buy shares
0.2 : 1
Mixed
Insider-held shares
9.29M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| May 27, 26 | STUKA PAUL Director |
BUY | 20.00K | $17.50K | Direct |
| May 19, 26 | GLEASON SHANE THOMAS Officer |
SELL | 85.30K | $189.59K | Direct |
| May 14, 26 | STUKA PAUL Director |
BUY | 15.00K | $17.32K | Direct |
| May 12, 26 | SLOSMAN MARVIN Chief Executive Officer |
BUY | 21.00K | $25.20K | Direct |
| May 11, 26 | STUKA PAUL Director |
BUY | 75.63K | $88.03K | Direct |
| May 11, 26 | STUKA PAUL Director |
BUY | 75.63K | $88.03K | Direct |
| May 7, 26 | ROUBIN GARY S Director |
BUY | 90.00K | $106.20K | Direct |
| May 7, 26 | WARD SCOTT RAYMOND Director |
BUY | 89.25K | $102.64K | Direct |
| May 7, 26 | STUKA PAUL Director |
BUY | 7.89K | $9.03K | Direct |
| Feb 2, 26 | GLEASON SHANE THOMAS Officer |
SELL | 61.19K | $99.33K | Direct |
| Jan 14, 26 | STUKA PAUL Director |
STOCK | 132.08K | $0 | Direct |
| Jan 14, 26 | DEAREN DANNY L Director |
STOCK | 44.03K | $0 | Direct |
| Jan 14, 26 | LAWLESS MICHAEL A. Chief Financial Officer |
STOCK | 226.69K | $0 | Direct |
| Jan 14, 26 | GLEASON SHANE THOMAS Officer |
STOCK | 453.39K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BERMAN MICHAEL |
Director | 597.58K | Stock Award(Grant) |
GLEASON SHANE THOMAS |
Officer | 1.05M | Sale |
KESTER THOMAS J |
Director | 458.57K | Stock Award(Grant) |
LAWLESS MICHAEL A. |
Chief Financial Officer | 691.70K | Stock Award(Grant) |
ROUBIN GARY S |
Director | 834.48K | Purchase |
SHORE CRAIG |
Chief Financial Officer | 1.11M | Stock Award(Grant) |
SLOSMAN MARVIN |
Chief Executive Officer | 3.56M | Purchase |
STUKA PAUL |
Director | 1.09M | Purchase |
TOMMASOLI ANDREA |
Chief Operating Officer | 954.39K | Stock Award(Grant) |
VERTA PATRICK |
Officer | 311.53K | Stock Award(Grant) |
Fundamentals
Market cap$24.42M
Enterprise value$-2.98M
Revenue (TTM)$10.84M
Gross profit$1.96M
EBITDA$-52.98M
Net income$-52.48M
EPS (TTM)$-0.62
Free cash flow$-23.11M
Total cash$30.42M
Total debt$3.02M
Book value / share$0.67
Shares outstanding46.49M
Float28.72M
Short % of float0.06%
Dividend yield0.00%
Beta (5Y)0.83
Valuation & profitability ratios
Trailing P/E—
Forward P/E-1.09
PEG ratio—
Price / sales—
Price / book0.78
EV / revenue-0.28
EV / EBITDA0.06
Gross margin18.05%
Operating margin-815.64%
Profit margin0.00%
Return on equity-202.81%
Return on assets-85.85%
Debt / equity9.60
Current ratio3.80
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $8.98M | $7.01M | $6.21M | $5.17M | +28.1% |
| Operating revenue | $8.98M | $7.01M | $6.21M | $5.17M | +28.1% |
| Cost of revenue | $6.33M | $5.50M | $4.40M | $4.05M | +15.0% |
| Gross profit | $2.65M | $1.51M | $1.81M | $1.12M | +75.9% |
| Research & development | $15.00M | $13.63M | $7.98M | $7.81M | +10.0% |
| Selling, general & admin | $37.26M | $21.38M | $14.97M | $12.02M | +74.3% |
| Total operating expense | $52.26M | $35.01M | $22.95M | $19.83M | +49.3% |
| Operating income | -$49.61M | -$33.50M | -$21.14M | -$18.71M | -48.1% |
| Net interest income | $891.00K | $1.56M | $1.29M | $250.00K | -42.8% |
| Pre-tax income | -$48.72M | -$31.95M | -$19.85M | -$18.46M | -52.5% |
| Tax provision | $63.00K | $59.00K | $65.00K | $28.00K | +6.8% |
| Net income | -$48.79M | -$32.01M | -$19.92M | -$18.49M | -52.4% |
| Net income to common | -$48.79M | -$32.01M | -$19.92M | -$18.49M | -52.4% |
| Basic EPS | -0.76 | -0.76 | -0.82 | -2.35 | 0.0% |
| Diluted EPS | -0.76 | -0.76 | -0.82 | -2.35 | 0.0% |
| EBIT | -$49.61M | -$33.50M | -$21.14M | -$18.71M | -48.1% |
| EBITDA | -$49.14M | -$33.22M | -$20.91M | -$18.52M | -47.9% |
| Basic shares | 64.33M | 41.93M | 24.27M | 7.87M | +53.4% |
| Diluted shares | 64.33M | 41.93M | 24.27M | 7.87M | +53.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $8.94M | $18.92M | $9.64M | $4.63M | -52.7% |
| Cash & short-term investments | $54.21M | $34.64M | $39.02M | $17.80M | +56.5% |
| Accounts receivable | $2.17M | $1.57M | $1.80M | $1.03M | +37.9% |
| Inventory | $3.40M | $2.57M | $2.11M | $1.62M | +32.1% |
| Total current assets | $61.47M | $40.52M | $44.16M | $21.33M | +51.7% |
| Property, plant & equipment | $6.34M | $4.73M | $2.53M | $2.47M | +34.1% |
| Total assets | $69.40M | $46.81M | $47.64M | $24.65M | +48.3% |
| Total current liabilities | $10.71M | $7.68M | $6.02M | $5.07M | +39.5% |
| Total debt | $3.29M | $2.34M | $1.59M | $1.61M | +40.7% |
| Total liabilities | $14.20M | $10.72M | $8.14M | $7.26M | +32.5% |
| Retained earnings | -$302.29M | -$253.51M | -$221.50M | -$201.59M | -19.2% |
| Shareholder equity | $55.20M | $36.09M | $39.50M | $17.39M | +53.0% |
| Working capital | $50.76M | $32.84M | $38.14M | $16.26M | +54.6% |
| Net tangible assets | $55.20M | $36.09M | $39.50M | $17.39M | +53.0% |
| Shares issued | 43.53M | 26.61M | 21.84M | 8.33M | +63.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$48.79M | -$32.01M | -$19.92M | -$18.49M | -52.4% |
| Depreciation & amortisation | $476.00K | $280.00K | $232.00K | $188.00K | +70.0% |
| Stock-based compensation | $12.33M | $10.14M | $4.49M | $2.35M | +21.6% |
| Change in working capital | $1.11M | $736.00K | -$801.00K | $395.00K | +50.3% |
| Operating cash flow | -$35.10M | -$21.87M | -$16.38M | -$15.54M | -60.5% |
| Capital expenditure | -$1.66M | -$1.40M | -$381.00K | -$473.00K | -18.5% |
| Investing cash flow | -$30.56M | $12.64M | -$16.09M | $8.44M | -341.8% |
| Financing cash flow | $55.57M | $18.45M | $37.53M | -$140.00K | +201.2% |
| Free cash flow | -$36.77M | -$23.27M | -$16.76M | -$16.02M | -58.0% |
| End cash position | $8.94M | $18.92M | $9.64M | $4.63M | -52.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $1.77M | $3.40M | $3.15M | $2.52M | $1.78M | -47.9% |
| Operating revenue | $1.77M | $3.40M | $3.15M | $2.52M | $1.78M | -47.9% |
| Cost of revenue | $2.54M | $2.71M | $1.97M | $1.66M | $1.47M | -6.1% |
| Gross profit | -$774.00K | $687.00K | $1.18M | $864.00K | $313.00K | -212.7% |
| Research & development | $4.29M | $4.76M | $3.48M | $3.63M | $3.83M | -9.8% |
| Selling, general & admin | $9.38M | $9.90M | $9.79M | $10.28M | $9.50M | -5.3% |
| Total operating expense | $13.67M | $14.66M | $13.26M | $13.91M | $13.33M | -6.8% |
| Operating income | -$14.45M | -$13.98M | -$12.08M | -$13.05M | -$13.02M | -3.3% |
| Net interest income | $121.00K | $289.00K | $386.00K | $343.00K | -$132.00K | -58.1% |
| Pre-tax income | -$14.32M | -$13.69M | -$11.70M | -$12.71M | -$13.15M | -4.6% |
| Net income | -$14.32M | -$13.69M | -$11.76M | -$12.71M | -$13.15M | -4.6% |
| Net income to common | -$14.32M | -$13.69M | -$11.76M | -$12.71M | -$13.15M | -4.6% |
| Basic EPS | -0.17 | -0.16 | -0.14 | -0.17 | -0.26 | -6.3% |
| Diluted EPS | -0.17 | -0.16 | -0.14 | -0.17 | -0.26 | -6.3% |
| EBIT | -$14.45M | -$13.98M | -$12.08M | -$13.05M | -$13.02M | -3.3% |
| EBITDA | -$14.29M | -$13.83M | -$11.94M | -$12.92M | -$12.91M | -3.3% |
| Basic shares | 84.66M | 83.80M | 82.37M | 73.47M | 51.00M | +1.0% |
| Diluted shares | 84.66M | 83.80M | 82.37M | 73.47M | 51.00M | +1.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $15.15M | $11.36M | $8.94M | $63.40M | $11.51M | +33.3% |
| Cash & short-term investments | $30.42M | $41.57M | $54.21M | $63.40M | $19.37M | -26.8% |
| Accounts receivable | $1.82M | $2.38M | $2.17M | $1.96M | $1.59M | -23.7% |
| Inventory | $2.70M | $3.04M | $3.40M | $3.61M | $3.05M | -11.0% |
| Total current assets | $36.63M | $48.59M | $61.47M | $70.39M | $25.46M | -24.6% |
| Property, plant & equipment | $6.29M | $6.25M | $6.34M | $6.32M | $6.17M | +0.6% |
| Total assets | $44.64M | $56.47M | $69.40M | $78.47M | $33.34M | -20.9% |
| Total current liabilities | $9.65M | $9.44M | $10.71M | $10.82M | $9.07M | +2.1% |
| Total debt | $3.02M | $3.11M | $3.29M | $3.37M | $3.42M | -2.7% |
| Total liabilities | $13.13M | $12.85M | $14.20M | $14.36M | $13.10M | +2.1% |
| Retained earnings | -$330.31M | -$315.98M | -$302.29M | -$290.53M | -$277.82M | -4.5% |
| Shareholder equity | $31.51M | $43.62M | $55.20M | $64.11M | $20.24M | -27.8% |
| Working capital | $26.98M | $39.15M | $50.76M | $59.58M | $16.39M | -31.1% |
| Net tangible assets | $31.51M | $43.62M | $55.20M | $64.11M | $20.24M | -27.8% |
| Shares issued | 46.84M | 46.84M | 43.53M | 41.92M | 32.55M | -0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$14.32M | -$13.69M | -$11.76M | -$12.71M | -$13.15M | -4.6% |
| Depreciation & amortisation | $158.00K | $149.00K | $143.00K | $128.00K | $107.00K | +6.0% |
| Stock-based compensation | $2.22M | $2.10M | $2.85M | $3.54M | $3.21M | +5.4% |
| Change in working capital | $996.00K | -$1.05M | $80.00K | $325.00K | $1.24M | +194.4% |
| Operating cash flow | -$10.89M | -$12.34M | -$9.35M | -$8.63M | -$8.33M | +11.7% |
| Capital expenditure | -$330.00K | -$194.00K | -$398.00K | -$329.00K | -$576.00K | -70.1% |
| Investing cash flow | $14.65M | $14.78M | -$45.13M | $7.55M | $5.32M | -0.9% |
| Financing cash flow | $0 | $0 | $0 | $52.93M | $2.14M | — |
| Free cash flow | -$11.22M | -$12.53M | -$9.74M | -$8.96M | -$8.91M | +10.4% |
| End cash position | $15.15M | $11.36M | $8.94M | $63.40M | $11.51M | +33.3% |
Options analytics
Put / call volume
1.00
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
2.50
+376.0% from spot
ATM implied vol
50.0%
Nearest strike to spot
Skew (10% OTM)
-50.0%
Calls bid over puts
Call volume
1
Contracts, this expiry
Put volume
1
Contracts, this expiry
Heaviest call OI
2.50
0 contracts
Heaviest put OI
2.50
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.20 | -0.17 | +15.0% |
| Mar 2026 | -0.18 | -0.16 | +11.1% |
| Dec 2025 | -0.19 | -0.14 | +27.6% |
| Sep 2025 | -0.20 | -0.17 | +12.8% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.15 | 3 | $2.00M | -20.9% |
| Next quarter | -0.13 | 3 | $2.66M | -15.6% |
| Current year | -0.45 | 3 | $9.80M | +9.1% |
| Next year | -0.48 | 3 | $20.13M | +105.4% |
Analyst targets & ownership
Mean target$3.33
High target$4.00
Low target$3.00
Implied upside534.68%
Analyst count3
ConsensusNONE
Strong buy / Buy2 / 1
Hold0
Sell / Strong sell0 / 0
Held by insiders19.98%
Held by institutions46.31%
Institutions holding38
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.65
-19.82% from price
SMA 20
0.71
-25.87% from price
SMA 50
0.78
-31.93% from price
SMA 100
0.79
-33.44% from price
SMA 200
1.20
-55.69% from price
EMA 12
0.66
-19.97% from price
EMA 26
0.72
-26.72% from price
EMA 50
0.76
-31.01% from price
RSI (14)
18.5
Oversold
MACD (12,26,9)
-0.06
Hist -0.02
ATR (14)
0.07
12.53% of price
Realised vol 30D
57.7%
Annualised
Bollinger upper
0.87
20, 2σ
Bollinger lower
0.56
20, 2σ
50 / 200 cross
Death
0.78 vs 1.20
Trend bias
Below 200
-55.69%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.83
Less volatile than market
Correlation to SPY
0.17
Largely independent
Realised vol 30D
57.7%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-78.8%
Peak to trough
Max drawdown 5Y
-87.8%
Peak to trough
ATR 14
0.07
12.53% of price
Beta (reported)
0.83
5Y monthly, from filing
Short interest
Shares short
25.36K
Prior 85.34K
Change vs prior
-70.3%
Shorts covering
% of float
0.06%
Normal
% of shares out
0.05%
Against total outstanding
Days to cover
0.3
Liquid
Float
28.72M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 5, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| May 12, 25 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Dec 11, 24 | Lake Street | INITIATED | — | Buy |
| Nov 2, 23 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Jun 12, 23 | Piper Sandler | INITIATED | — | Overweight |
| May 17, 23 | National Alliance Securities | MAINTAINED | — | Buy |
| Mar 31, 23 | Alliance Global Partners | MAINTAINED | — | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay dateApr 1, 2019
Last split1:15
Split dateApr 27, 2021
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-21
Corporate Changes & Voting Matters
8-K · 2026-08-17
Periodic Financial Reports
10-Q · 2026-08-14
Corporate Changes & Voting Matters
8-K · 2026-07-29
Corporate Changes & Voting Matters
8-K · 2026-07-23
Corporate Changes & Voting Matters
8-K · 2026-07-02
Corporate Changes & Voting Matters
8-K · 2026-06-11
Corporate Changes & Voting Matters
8-K · 2026-06-03
Headlines
InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 Million
GlobeNewswire · 16d ago
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · 33d ago
InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · 34d ago
InspireMD (NSPR) Upgraded to Buy: Here's What You Should Know
Zacks · 48d ago
InspireMD Inc (NSPR) (Q2 2026) Earnings Call Highlights: Navigating Recall Challenges While ...
GuruFocus.com · 50d ago
InspireMD, Inc. Q2 2026 Earnings Call Summary
Moby · 51d ago
InspireMD Reports Second Quarter 2026 Financial Results
GlobeNewswire · 51d ago
InspireMD, Inc. (NSPR) Reports Q2 Loss, Beats Revenue Estimates
Zacks · 53d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.